Skip to main content
Faes Farma S.A. logo

Faes Farma S.A. — Investor Relations & Filings

Ticker · FAE ISIN · ES0134950F36 LEI · 959800FXZQY7U3P1G969 MC Manufacturing
Open in API
Filings indexed 193 across all filing types
Latest filing 2023-10-09 Transaction in Own Shar…
Country ES Spain
Listing MC FAE

About Faes Farma S.A.

https://faesfarma.com/en/

Faes Farma S.A. is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical products, healthcare solutions, and animal nutrition products. The company's pharmaceutical division develops treatments for conditions in therapeutic areas including allergy, gastroenterology, and immunology, with key proprietary molecules such as Bilastine, a leading antihistamine, and Calcifediol for Vitamin D deficiency. The animal nutrition business provides nutritional solutions and supplements for sustainable animal production. A core focus of the company is its investment in R&D to develop novel molecules and health solutions for its global markets.

Recent filings

Filing Released Lang Actions
La Sociedad informa de las operaciones de acciones propias realizadas del 2 al 6 de octubre al amparo de su Programa de Recompra
Transaction in Own Shares Classification · 100% confidence The document is a formal communication to the 'COMISIÓN NACIONAL DEL MERCADO DE VALORES' (CNMV, the Spanish securities market regulator) under the heading 'OTRA INFORMACIÓN RELEVANTE' (Other Relevant Information). The content explicitly details the execution of a share repurchase program ('programa de recompra de acciones propias') over a specific period (October 2 to October 6, 2023), including transaction dates, quantities, and prices. This type of filing, reporting the company's own transactions in its shares, directly corresponds to the definition of 'Transaction in Own Shares' (POS). It is not a general regulatory filing (RNS) because it fits a specific category, nor is it a general announcement of a report (RPA).
2023-10-09 Spanish
La Sociedad informa de las operaciones de acciones propias realizadas del 25 al 29 de septiembre al amparo de su Programa de Recompra
Transaction in Own Shares Classification · 100% confidence The document is a formal communication to the 'COMISIÓN NACIONAL DEL MERCADO DE VALORES' (CNMV, the Spanish securities market regulator) under the heading 'OTRA INFORMACIÓN RELEVANTE' (Other Relevant Information). The content explicitly details the execution of a share repurchase program ('programa de recompra de acciones propias') over a specific period (September 25 to 29, 2023), including transaction dates, quantities, and prices. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares' (POS). It is not a general earnings release (ER), a full annual report (10-K), or a management discussion (MDA), but a specific regulatory disclosure about treasury stock transactions.
2023-10-03 Spanish
La Sociedad informa de las operaciones de acciones propias realizadas del 18 al 22 de septiembre al amparo de su Programa de Recompra
Transaction in Own Shares Classification · 99% confidence The document is a formal communication to the CNMV (Comisión Nacional del Mercado de Valores) titled 'OTRA INFORMACIÓN RELEVANTE' (Other Relevant Information). The content explicitly details transactions carried out by the company (Faes Farma, S.A.) involving the purchase of its own shares ('compra de acciones propias') during a specific period (September 18 to 22, 2023), referencing the share repurchase program ('Programa de Recompra'). This activity directly corresponds to the definition of a company reporting transactions in its own shares. Therefore, the appropriate classification is Transaction in Own Shares (POS).
2023-09-25 Spanish
La Sociedad informa de las operaciones de acciones propias realizadas del 11 al 15 de septiembre al amparo de su Programa de Recompra
Transaction in Own Shares Classification · 99% confidence The document is a formal communication addressed to the 'COMISIÓN NACIONAL DEL MERCADO DE VALORES' (CNMV, the Spanish securities market regulator) under the heading 'OTRA INFORMACIÓN RELEVANTE' (Other Relevant Information). The content explicitly details transactions carried out by Faes Farma, S.A. regarding the 'programa de recompra de acciones propias' (share repurchase program) during a specific period (September 11 to 15, 2023). This involves the company buying back its own shares. According to the definitions, the category 'Transaction in Own Shares' (Code: POS) covers reports of the company buying back or selling its own shares (share repurchase/issuance). The document is a detailed report of these transactions, not just an announcement of a report's publication.
2023-09-18 Spanish
La Sociedad informa de las operaciones de acciones propias realizadas del 4 al 8 de septiembre al amparo de su Programa de Recompra
Transaction in Own Shares Classification · 100% confidence The document is a formal communication to the 'COMISIÓN NACIONAL DEL MERCADO DE VALORES' (CNMV, the Spanish securities market regulator) under the heading 'OTRA INFORMACIÓN RELEVANTE' (Other Relevant Information). The content explicitly details the purchase of the company's own shares ('compra de acciones propias') during a specific period (September 4 to 8, 2023) as part of an existing share repurchase program. This activity—the company buying back its own stock—directly corresponds to the definition of 'Transaction in Own Shares'. The code for this is POS.
2023-09-11 Spanish
La Sociedad informa de las operaciones de acciones propias realizadas del 24 de agosto al 1 de septiembre al amparo de su Programa de Recompra
Transaction in Own Shares Classification · 100% confidence The document is a formal communication to the 'COMISIÓN NACIONAL DEL MERCADO DE VALORES' (CNMV, the Spanish securities market regulator) under the heading 'OTRA INFORMACIÓN RELEVANTE' (Other Relevant Information). The content explicitly details the execution of a share repurchase program ('programa de recompra de acciones propias') over a specific period (August 24 to September 1, 2023), including transaction dates, quantities, and prices. This type of filing, reporting the company's own transactions in its shares, directly corresponds to the definition of 'Transaction in Own Shares' (POS). It is not a general regulatory filing (RNS) because it fits a specific category, nor is it a capital change announcement (SHA) which usually relates to issuance or splits, although repurchases affect capital structure, POS is the most precise fit for buybacks.
2023-09-04 Spanish

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.